Literature DB >> 23536619

To evaluate the effect of combining photo-activation therapy with platelet-rich plasma injections for the novel treatment of osteoarthritis.

Julien Ben Freitag1, Adele Barnard.   

Abstract

OBJECTIVE: To evaluate the effect of combining photo-activation therapy with platelet-rich plasma injections for the novel treatment of osteoarthritis.
DESIGN: We present a case report of osteoarthritis of the knee treated with photo-activated platelet-rich plasma injections (PAPRP).
METHODS: After utilising conventional osteoarthritis treatment methods a patient underwent a course of PAPRP injections. The patient outcome was measured using the numerical pain rating scale (NPRS) and the Western Ontario and McMaster Universities Arthritis (WOMAC) Index.
RESULTS: Following treatment the patient reported improvements in both pain and function as measured by the NPRS and WOMAC Index, respectively. The patient was followed up for 18 weeks, at which time no significant complications were noted.
CONCLUSIONS: In this case report of osteoarthritis, with strict control of conventional therapy variables, PAPRP injections demonstrated improvement in all recorded outcome measures. The results of this case report highlight the need to further investigate the use of PAPRP in the treatment of symptomatic knee osteoarthritis.

Entities:  

Mesh:

Year:  2013        PMID: 23536619      PMCID: PMC3618722          DOI: 10.1136/bcr-2012-007463

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  23 in total

Review 1.  The role of the interleukin-1-receptor antagonist in blocking inflammation mediated by interleukin-1.

Authors:  C A Dinarello
Journal:  N Engl J Med       Date:  2000-09-07       Impact factor: 91.245

2.  Radiological assessment of osteo-arthrosis.

Authors:  J H KELLGREN; J S LAWRENCE
Journal:  Ann Rheum Dis       Date:  1957-12       Impact factor: 19.103

Review 3.  Interleukin-1 receptor antagonist: role in biology.

Authors:  W P Arend; M Malyak; C J Guthridge; C Gabay
Journal:  Annu Rev Immunol       Date:  1998       Impact factor: 28.527

4.  Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee.

Authors:  N Bellamy; W W Buchanan; C H Goldsmith; J Campbell; L W Stitt
Journal:  J Rheumatol       Date:  1988-12       Impact factor: 4.666

Review 5.  Osteoarthritis and cartilage: the role of cytokines.

Authors:  M B Goldring
Journal:  Curr Rheumatol Rep       Date:  2000-12       Impact factor: 4.592

6.  Treatment of knee joint osteoarthritis with autologous platelet-rich plasma in comparison with hyaluronic acid.

Authors:  Tímea Spaková; Ján Rosocha; Marek Lacko; Denisa Harvanová; Ahmed Gharaibeh
Journal:  Am J Phys Med Rehabil       Date:  2012-05       Impact factor: 2.159

Review 7.  The role of cytokines in cartilage matrix degeneration in osteoarthritis.

Authors:  Steven R Goldring; Mary B Goldring
Journal:  Clin Orthop Relat Res       Date:  2004-10       Impact factor: 4.176

8.  Knee Injury and Osteoarthritis Outcome Score (KOOS)--development of a self-administered outcome measure.

Authors:  E M Roos; H P Roos; L S Lohmander; C Ekdahl; B D Beynnon
Journal:  J Orthop Sports Phys Ther       Date:  1998-08       Impact factor: 4.751

Review 9.  The role of cytokines in osteoarthritis pathophysiology.

Authors:  Julio C Fernandes; Johanne Martel-Pelletier; Jean-Pierre Pelletier
Journal:  Biorheology       Date:  2002       Impact factor: 1.875

Review 10.  Interleukin-1 and interleukin-1 antagonism.

Authors:  C A Dinarello
Journal:  Blood       Date:  1991-04-15       Impact factor: 22.113

View more
  4 in total

1.  Leukocyte-poor PRP application for the treatment of knee osteoarthritis.

Authors:  Giuseppe Filardo; Elizaveta Kon; Berardo DI Matteo; Alessandro DI Marino; Andrea Sessa; Maria Letizia Merli; Maurilio Marcacci
Journal:  Joints       Date:  2014-01-08

2.  Intra-articular injection of photo-activated platelet-rich plasma in patients with knee osteoarthritis: a double-blind, randomized controlled pilot study.

Authors:  Kade L Paterson; Melissa Nicholls; Kim L Bennell; Dan Bates
Journal:  BMC Musculoskelet Disord       Date:  2016-02-09       Impact factor: 2.362

3.  The effect of autologous adipose derived mesenchymal stem cell therapy in the treatment of a large osteochondral defect of the knee following unsuccessful surgical intervention of osteochondritis dissecans - a case study.

Authors:  Julien Freitag; Kiran Shah; James Wickham; Richard Boyd; Abi Tenen
Journal:  BMC Musculoskelet Disord       Date:  2017-07-14       Impact factor: 2.362

4.  Glenohumeral Osteoarthritis: The Role for Orthobiologic Therapies: Platelet-Rich Plasma and Cell Therapies.

Authors:  Luciano A Rossi; Nicolás S Piuzzi; Shane A Shapiro
Journal:  JBJS Rev       Date:  2020-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.